21 | Add to Reading ListSource URL: ww2.rheumatology.orgLanguage: English - Date: 2012-11-10 11:05:30
|
|---|
22 | Add to Reading ListSource URL: www.lifelabs.comLanguage: English - Date: 2014-07-22 17:37:52
|
|---|
23 | Add to Reading ListSource URL: ww2.rheumatology.orgLanguage: English - Date: 2012-11-20 16:33:27
|
|---|
24 | Add to Reading ListSource URL: www.bcguidelines.caLanguage: English - Date: 2014-01-07 12:50:14
|
|---|
25![Traditional 5 10(k) Premarket Notification IMMULITE® 2000 Anti-CCP IgO Assay 510O(k) Summary of Safety and Effectiveness IMMULITE® 2000 Anti-CCP lgG Assay APR[removed]](https://www.pdfsearch.io/img/a8ca89da2ae92a95cade14ba5ab4b414.jpg "Traditional 5 10(k) Premarket Notification IMMULITE® 2000 Anti-CCP IgO Assay 510O(k) Summary of Safety and Effectiveness IMMULITE® 2000 Anti-CCP lgG Assay APR[removed]") | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-05-06 11:19:23
|
|---|
26 | Add to Reading ListSource URL: www.augurex.comLanguage: English - Date: 2012-11-27 18:33:34
|
|---|
27![BLOOD MARKER CAN HELP DIAGNOSE RHEUMATOID ARTHRITIS; NEW DATA AT THE 2012 ANNUAL MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY Vancouver, BC – November 14, [removed]International arthritis investigators this week at th](https://www.pdfsearch.io/img/93f588c5a675a7f6102c5d78a0cb38e1.jpg "BLOOD MARKER CAN HELP DIAGNOSE RHEUMATOID ARTHRITIS; NEW DATA AT THE 2012 ANNUAL MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY Vancouver, BC – November 14, [removed]International arthritis investigators this week at th") | Add to Reading ListSource URL: www.augurex.comLanguage: English - Date: 2012-11-27 18:33:34
|
|---|
28![Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker[removed]η as a Testing Service in the U.S. Vancouver, BC – October 9, [removed]Augurex Life Sciences Corp. to](https://www.pdfsearch.io/img/3dfae37adba920f5a280f37066003183.jpg "Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker[removed]η as a Testing Service in the U.S. Vancouver, BC – October 9, [removed]Augurex Life Sciences Corp. to") | Add to Reading ListSource URL: www.augurex.comLanguage: English - Date: 2012-11-27 18:33:44
|
|---|
29![Presented at ACR 2011 Presentation Number 378 Extracellular[removed]η: An Early RA Pathogenic Factor 1 2](https://www.pdfsearch.io/img/cf1ef847bb0fba9600dea6228d5cef88.jpg "Presented at ACR 2011 Presentation Number 378 Extracellular[removed]η: An Early RA Pathogenic Factor 1 2") | Add to Reading ListSource URL: www.augurex.comLanguage: English - Date: 2012-11-27 18:32:48
|
|---|
30![[removed]ETA IS AN EARLY RA BIOMARKER THAT IS MODIFIABLE WITH STANDARD DMARDS AND CORRESPONDS WITH IMPROVEMENT IN CLINICAL VARIABLES 1,* 2](https://www.pdfsearch.io/img/c870fac4b99b9edd7b087be605c99c51.jpg "[removed]ETA IS AN EARLY RA BIOMARKER THAT IS MODIFIABLE WITH STANDARD DMARDS AND CORRESPONDS WITH IMPROVEMENT IN CLINICAL VARIABLES 1,* 2") | Add to Reading ListSource URL: www.augurex.comLanguage: English - Date: 2013-07-02 21:51:08
|
|---|